Table 3.
Predictors of in-hospital mortality among patients with ST-elevation myocardial infarction
| Odds ratio (95% confidence interval)
|
||
|---|---|---|
| Unadjusted | Adjusted | |
| Variable | n = 9186 | n = 7794 |
| Age | 1.05 (1.04–1.06)* | 1.03 (1.02–1.04)† |
| Sex, female | 1.97 (1.74–2.24)† | 1.33 (1.13–1.56)† |
| Medical history | ||
| Hypertension | 0.94 (0.83–1.06) | 0.77 (0.66–0.91)* |
| Diabetes mellitus | 1.35 (1.17–1.56)† | 1.16 (0.98–1.39) |
| Lipid disorders | 0.60 (0.52–0.68)† | 0.70 (0.60–0.83)† |
| Current smoker | 0.49 (0.42–0.54)† | 0.80 (0.67–0.95)* |
| Prior myocardial infarction | 2.01 (1.70–2.39)† | 1.67 (1.36–2.05)† |
| Characteristics of the qualifying event | ||
| Anterior acute myocardial infarction | 1.58 (1.39–1.79)† | 1.44 (1.24–1.68)† |
| Killip class ≥ 2 | 5.10 (4.48–5.82)† | 4.27 (3.64–5.00)† |
| Tertiary referral hospital | 0.72 (0.64–0.82)† | 0.82 (0.70–0.97)* |
| Acute treatment | ||
| Thrombolysis within 2 h | 0.51 (0.42–0.61)† | 0.75 (0.61–0.92)* |
| Anticoagulant drugs | 0.66 (0.61–0.72)† | 0.65 (0.58–0.72)† |
| Antiplatelet drugs | 0.31 (0.26–0.37)† | 0.26 (0.21–0.33)† |
| Primary percutaneous intervention | 0.57 (0.33–0.99)* | 0.87 (0.45–1.68) |
*
p < 0.05.
†
p < 0.001.